This conference has been withdrawn from the 2020 conference schedule
As you are aware, coronavirus is having a global impact and the World Health Organization and the Centers for Disease Control have instituted recommendations that include social distancing and cancelling conferences and large gatherings. Since safety of our attendees is always GRC's highest priority, the GRC Board of Trustees has decided to withdraw this conference and it will be rescheduled for 2022. This decision was made out of an abundance of caution and to alleviate the concerns of our conference communities that are scheduled to meet in this timeframe.
Structure elucidation plays an essential role in understanding the fundamental biology of diseases and in discovering and developing novel therapies to improve human health. In recent years, there have been substantial research efforts to develop new therapies to tackle disease areas where traditional small molecules and large molecules have had their limitations. These new modalities include peptides, oligonucleotides, macrocycles, polymer drug conjugates, antibody/bispecific antibody drug conjugates, and many others. With the increasing complexity of small molecules, large molecules and new modalities, the success of structure elucidation requires an array of complementary analytical technologies rather than a particular one. Additionally, new analytical technologies will need to be developed. This conference will highlight major developments in analytical technologies and applications in core areas of structure elucidation and biological function. Furthermore, the conference will bring the best researchers from academia, analytical instrument and pharmaceutical industries. The conference's aim is to encourage collaborations between the industry and academia with the ultimate goal to transform fundamental science into meaningful therapeutics.